LATEST UPDATES » Vol 23, No 04, April 2019 – Career development for researchers       » CRISPR not as precise as thought       » Insomnia spreads among young Chinese       » Chinese HEV vaccine begin clinical trial in U.S       » Eating mushrooms may reduce risk of cognitive decline       » Green tea cuts obesity in mice      
INSIDE INDUSTRY For e-subscribers (PDF)
Vol 22, No 03, March 2018
Biotech merger and acquisition deal activity skyrockets in early 2018

GlobalData says companies with therapies that have recently gained approval or are likely to gain approval within high-impact disease areas as well as those that focus on oncology, rare diseases, and gene-editing technologies are likely to gain interest.

Telix Pharmaceuticals establishes Japanese Subsidiary, appoints key executives

To lead the Telix Japan activities, Dr. Shintaro Nishimura and Dr. Takeshi Oka have been appointed as president and chief operating officer, and chief medical officer (Japan), respectively.

Engine Biosciences raises US$10 million in largest institutional seed financing in South East Asia

Singapore and San Francisco-based biotech company raises US$10 million in seed round from leading American and Asian investors; round was co-led by DHVC (Danhua Capital) and 6 Dimensions Capital, with participation from WuXi Apptec, EDBI, Pavilion Capital, Baidu Ventures, WI Harper, and Nest.Bio Ventures.

Vetter introduces South Korea's pharma and biotech community to meet company management

South Korea conducive for pharma and biotech companies for its rapidly growing local economy and regulatory environment.

Anatara achieves major US FDA milestone in the registration of Detach? with approval of the Human Food Safety Dossier

US Food and Drug Administration is satisfied that food products from animals treated using Detach? will be safe for human consumption.

FIP appoints new chief executive officer

Dr Catherine Duggan to become FIP's CEO, charged with ensuring organisation is the global voice for four million practitioners and scientists around the world.

Accuron MedTech partners SPRING Singapore to co-invest in Singapore's innovative start-ups

Accuron MedTech appointed by SPRING Singapore to identify, co-invest and grow high-potential deep technology start-ups and to invest S$10 million in the Health and Biomedical Sciences sector.

Tychan's first-in-class Zika monoclonal antibody therapeutics ready for human trial after nine months of development

Tychan establishes Joint-Partnership with WuXi Biologics to develop Therapeutics in three areas including Zika Virus. Focused on developing quick and effective response against deadly infectious diseases.

Merck invests additional €40 million to enhance manufacturing and distribution in Asia

Investment supports growing demand for biopharmaceutical manufacturing. Builds capabilities with two new manufacturing and distribution centres in South Korea and India. Accelerates Mobius? single-use manufacturing in China for biosimilars development.

news Which country has the worst sleepers
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
Asia Pacific Biotech News

APBN Editorial Calendar 2019
Taiwan Medical tourism
Marijuana as medicine — Legal marijuana will open up scientific research
Driven by curiosity
Career developments for researchers
Editorial calendar is subjected to changes.
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy